Status: Current Investments

Health prediction company utilizing proteomics and advanced statistical techniques to better predict and improve health outcomes.

Commercial-stage life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing.

Clinical-stage biotechnology company focused on enabling cures with hematopoietic stem cell therapies.

Merged with Amplitude Healthcare Acquisition Corporation in 2021

Commercial-stage specialty pharmaceutical company focused on gastrointestinal, dermatological, and women’s health products.

Clinical-stage therapeutics company focused on the central nervous system (CNS), orphan diseases, and conditions with high unmet medical need.